Lv3
230 积分 2024-01-15 加入
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
20天前
已完结
Continuous Glucose Monitoring Use in Youth with Type 2 Diabetes: A Pilot Randomized Study
1个月前
已完结
MICROVASCULAR DYSFUNCTION IN PREECLAMPSIA AND GESTATIONAL DIABETES: A CASE-CONTROL STUDY
2个月前
已完结
Serum Glycome as a Diagnostic and Prognostic Factor in Gestational Diabetes Mellitus
2个月前
已完结
Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence
4个月前
已完结
Wearable and digital devices to monitor and treat metabolic diseases
5个月前
已完结
Diagnosis of Unruptured Intracranial Aneurysm by High‐Performance Serum Metabolic Fingerprints
6个月前
已完结
Deep Learning of Dual Plasma Fingerprints for High‐Performance Infection Classification
6个月前
已完结
SIRT5 safeguards against primate skeletal muscle ageing via desuccinylation of TBK1
6个月前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
7个月前
已关闭
皖公网安备34019202002308
